TY - JOUR
T1 - Intracellular signal transduction pathway proteins as targets for cancer therapy
AU - Adjei, Alex A.
AU - Hidalgo, Manuel
PY - 2005
Y1 - 2005
N2 - Circulating cytokines, hormones, and growth factors control all aspects of cell proliferation, differentiation, angiogenesis, apoptosis, and senescence. These chemical signals are propagated from the cell surface to intracellular processes via sequential kinase signaling, arranged in modules that exhibit redundancy and cross talk. This signal transduction system comprising growth factors, transmembrane receptor proteins, and cytoplasmic secondary messengers is often exploited to optimize tumor growth and metastasis in malignancies. Thus, it represents an attractive target for cancer therapy. This review will summarize current knowledge of selected intracellular signaling networks and their role in cancer therapy. The focus will be on pathways for which inhibitory agents are currently undergoing clinical testing. Original data for inclusion in this review were identified through a MEDLINE search of the literature. All papers from 1966 through March 2005 were identified by the following search terms: "signal transduction," "intracellular signaling," "kinases," "proliferation," "growth factors," and "cancer therapy." All original research and review papers related to the role of intracellular signaling in oncogenesis and therapeutic interventions relating to abnormal cell signaling were identified. This search was supplemented by a manual search of the Proceedings of the Annual Meetings of the American Association for Cancer Research, American Society of Clinical Oncology, and the American Association for Cancer Research (AARC) - European Organisation for Research and Treatment of Cancer (EORTC) - National Cancer Institute (NCI) Symposium on New Anticancer Drugs.
AB - Circulating cytokines, hormones, and growth factors control all aspects of cell proliferation, differentiation, angiogenesis, apoptosis, and senescence. These chemical signals are propagated from the cell surface to intracellular processes via sequential kinase signaling, arranged in modules that exhibit redundancy and cross talk. This signal transduction system comprising growth factors, transmembrane receptor proteins, and cytoplasmic secondary messengers is often exploited to optimize tumor growth and metastasis in malignancies. Thus, it represents an attractive target for cancer therapy. This review will summarize current knowledge of selected intracellular signaling networks and their role in cancer therapy. The focus will be on pathways for which inhibitory agents are currently undergoing clinical testing. Original data for inclusion in this review were identified through a MEDLINE search of the literature. All papers from 1966 through March 2005 were identified by the following search terms: "signal transduction," "intracellular signaling," "kinases," "proliferation," "growth factors," and "cancer therapy." All original research and review papers related to the role of intracellular signaling in oncogenesis and therapeutic interventions relating to abnormal cell signaling were identified. This search was supplemented by a manual search of the Proceedings of the Annual Meetings of the American Association for Cancer Research, American Society of Clinical Oncology, and the American Association for Cancer Research (AARC) - European Organisation for Research and Treatment of Cancer (EORTC) - National Cancer Institute (NCI) Symposium on New Anticancer Drugs.
UR - http://www.scopus.com/inward/record.url?scp=23944515326&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=23944515326&partnerID=8YFLogxK
U2 - 10.1200/JCO.2005.23.648
DO - 10.1200/JCO.2005.23.648
M3 - Review article
C2 - 15983388
AN - SCOPUS:23944515326
SN - 0732-183X
VL - 23
SP - 5386
EP - 5403
JO - Journal of Clinical Oncology
JF - Journal of Clinical Oncology
IS - 23
ER -